LT - Peptidai, veiksmingi navikų ir kitų ligų, reikalaujančių ląstelių pašalinimo arba destrukcijos, gydyme
EN - PEPTIDES EFFECTIVE IN THE TREATMENT OF TUMORS AND OTHER CONDITIONS REQUIRING THE REMOVAL OR DESTRUCTION OF CELLS
Legal status
Patent lapsed (non-payment of fees)
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C12N 15/12 |
(2006.01) |
|
|
A61K 31/7088 |
(2006.01) |
|
|
A61K 38/10 |
(2006.01) |
|
|
A61K 48/00 |
(2006.01) |
|
|
A61L 27/54 |
(2006.01) |
|
|
A61P 31/00 |
(2006.01) |
|
|
A61P 35/00 |
(2006.01) |
|
|
C07K 19/00 |
(2006.01) |
|
|
C07K 7/06 |
(2006.01) |
|
|
C07K 7/08 |
(2006.01) |
European patent
| (11) |
Number of the document |
1994152 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
07710660.7 |
|
Date of filing the European patent application |
2007-02-28 |
| (97) |
Date of publication of the European application |
2008-11-26 |
| (45) |
Date of publication and mention of the grant of the patent |
2012-12-12
|
| (46) |
Date of publication of the claims translation |
2013-03-25
|
PCT application
| (86) |
Number |
PCT/CA2007/000318 |
|
Date |
2007-02-28 |
PCT application publication
| (87) |
Number |
WO 2007/098588 |
|
Date |
2007-09-07 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
776933 P |
2006-02-28
|
US |
Inventors
| (72) |
AVERBACK, Paul, A., CA
GEMMELL, Jack, CA
|
Grantee
| (73) |
NYMOX CORPORATION,
9900 Boulevard Cavendish, Nr. 306, Saint-Laurent,Quebec H4M 2V2,
CA
|
Attorney or representative
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Title
| (54) |
Peptidai, veiksmingi navikų ir kitų ligų, reikalaujančių ląstelių pašalinimo arba destrukcijos, gydyme |
| |
PEPTIDES EFFECTIVE IN THE TREATMENT OF TUMORS AND OTHER CONDITIONS REQUIRING THE REMOVAL OR DESTRUCTION OF CELLS |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2023-07-19 |
17 |
520.50
EUR
|
Legal status
|
Patent lapsed (non-payment of fees)
|
|
|
Invalidation date |
2024-02-28 |
